UBS Group’s Japer Therapeutics, Inc. Warrants JSPRW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,304
| Closed | -$133 | – | 9145 |
|
|
2025
Q1 | $133 | Sell |
1,304
-1,268
| -49% | -$129 | ﹤0.01% | 8609 |
|
|
2024
Q4 | $437 | Buy |
+2,572
| New | +$437 | ﹤0.01% | 8225 |
|
|
2023
Q4 | – | Sell |
-37
| Closed | -$2 | – | 8321 |
|
|
2023
Q3 | $2 | Buy |
+37
| New | +$2 | ﹤0.01% | 8200 |
|
|
2022
Q4 | – | Sell |
-19,296
| Closed | -$1K | – | 9669 |
|
|
2022
Q3 | $1K | Buy |
19,296
+15,834
| +457% | +$821 | ﹤0.01% | 8866 |
|
|
2022
Q2 | $0 | Sell |
3,462
-300
| -8% | – | ﹤0.01% | 9490 |
|
|
2022
Q1 | $1K | Sell |
3,762
-1,000
| -21% | -$266 | ﹤0.01% | 8822 |
|
|
2021
Q4 | $7K | Buy |
+4,762
| New | +$7K | ﹤0.01% | 8029 |
|
|
2021
Q1 | – | Sell |
-11
| Closed | – | – | 8084 |
|
|
2020
Q4 | $0 | Sell |
11
-284
| -96% | – | ﹤0.01% | 7485 |
|
|
2020
Q3 | $0 | Buy |
+295
| New | – | ﹤0.01% | 7242 |
|